Bio-Rad Reports Second-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Bio-Rad Labs (BIO) Tops Q2 EPS by 39c
July 30, 2020 4:25 PM EDTBio-Rad Labs (NYSE: BIO) reported Q2 EPS of $1.61, $0.39 better than the analyst estimate of $1.22. Revenue for the quarter came in at $536.9 million versus the consensus estimate of $517.05 million.
2020 Financial Outlook
Given the uncertainties regarding the duration and impact of the COVID-19 pandemic, the company... More
